Group 1 - The company, Keta Bio (300858), operates in the food manufacturing industry, focusing on the research, production, and sales of edible probiotics, animal and plant micro-ecological preparations, and compound food additives [1] - The company has also made early investments in the pharmaceutical sector, collaborating with Shenzhen Unknown Jun Biotechnology Co., Ltd. to advance the research and development of probiotic drugs [1] - The company has accumulated a wealth of strain resources and key processes in core technologies, and its project on "Key Technology Creation and Application for the Excavation and Industrialization of Excellent Lactic Acid Bacteria Germplasm Resources" won the second prize of the 2023 National Science and Technology Progress Award [1]

Group 1 - The company, Kato Biotech, is actively advancing the research and development of probiotic new drug projects in collaboration with Shenzhen Unknown Jun Biotechnology Co., Ltd. and other pharmaceutical enterprises [1] - The company will provide timely information disclosure based on the progress of these projects [1]

Group 1 - The company is actively advancing its research and development of probiotic new drug projects in collaboration with Shenzhen Unknown Jun Biotechnology Co., Ltd. and other pharmaceutical enterprises [2] - The company will provide timely information disclosure based on the progress of these projects [2]

Group 1 - The company operates in the food manufacturing industry, focusing on the research, production, and sales of probiotic products, plant and animal micro-ecological preparations, and compound food additives [2] - The company has also made initial investments in the pharmaceutical sector, collaborating with Shenzhen Unknown Jun Biotechnology Co., Ltd. to advance the research and development of probiotic drugs [2] - The company has accumulated a rich resource of strains and key processes, and its project on "Key Technology Creation and Application for the Excavation and Industrialization of Excellent Lactic Acid Bacteria Germplasm Resources" won the second prize of the 2023 National Science and Technology Progress Award [2]

Core Viewpoint - The company is actively advancing the research and development of a probiotic new drug project in collaboration with Shenzhen Unknown Jun Biotechnology Co., Ltd [2] Group 1 - The company is currently engaged in a partnership with Shenzhen Unknown Jun Biotechnology Co., Ltd [2] - The research and development of the probiotic new drug project is progressing in an orderly manner [2] - The company will provide timely information disclosure based on the progress of the project [2]